205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.47%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-6.47%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-11.63%
Negative EBIT growth while QRVO is at 278.54%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-11.39%
Negative operating income growth while QRVO is at 172.12%. Joel Greenblatt would press for urgent turnaround measures.
-11.53%
Negative net income growth while QRVO stands at 102.15%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-10.81%
Negative EPS growth while QRVO is at 102.16%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-11.56%
Negative diluted EPS growth while QRVO is at 102.15%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.11%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.11%
Reduced diluted shares while QRVO is at 0.19%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
4.58%
Dividend growth of 4.58% while QRVO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
15.36%
Positive OCF growth while QRVO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
93.75%
Positive FCF growth while QRVO is negative. John Neff would see a strong competitive edge in net cash generation.
40.67%
10Y revenue/share CAGR under 50% of QRVO's 465.24%. Michael Burry would suspect a lasting competitive disadvantage.
22.37%
5Y revenue/share CAGR under 50% of QRVO's 70.43%. Michael Burry would suspect a significant competitive gap or product weakness.
-15.98%
Negative 3Y CAGR while QRVO stands at 2.26%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
80.26%
10Y OCF/share CAGR under 50% of QRVO's 880.92%. Michael Burry would worry about a persistent underperformance in cash creation.
16.53%
Below 50% of QRVO's 33.19%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-14.12%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
67.62%
Below 50% of QRVO's 502.08%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
15.21%
Positive 5Y CAGR while QRVO is negative. John Neff might view this as a strong mid-term relative advantage.
-42.90%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
86.70%
Below 50% of QRVO's 708.58%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
94.14%
5Y equity/share CAGR above 1.5x QRVO's 0.60%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
28.44%
Positive short-term equity growth while QRVO is negative. John Neff sees a strong advantage in near-term net worth buildup.
299.73%
Dividend/share CAGR of 299.73% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
50.84%
Stable or rising mid-term dividends while QRVO is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
18.30%
3Y dividend/share CAGR of 18.30% while QRVO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-7.68%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
5.38%
We show growth while QRVO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
0.53%
Positive asset growth while QRVO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-2.01%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-6.71%
We’re deleveraging while QRVO stands at 1.17%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-0.20%
Our R&D shrinks while QRVO invests at 9.47%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
4.21%
SG&A growth well above QRVO's 7.13%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.